Expression of the p53 homologue p63α and ΔNp63α in normal and neoplastic cells

Carcinogenesis

Volumn 21, Issue 2, 2000, Pages 153-160

  Hall, Peter A ^a,b   Campbell, Sandra J ^a   O'Neill, Mary ^a   Royston, Daniel J ^a   Nylander, Karin ^a   Carey, Frank A ^a   Kernohan, Neil M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALTERNATIVE RNA SPLICING; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BLOOD PROTEINS; BLOTTING, WESTERN; CELL DIVISION; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNE SERA; MEMBRANE PROTEINS; MITOMYCIN; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 0033982760     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Hall, P.A., Meek, D. and Lane, D.P. (1996) p53: integrating the complexity. J. Pathol., 180, 1-5.
2. Prives, C. and Hall, P.A. (1999) The p53 pathway. J. Pathol., 187, 112-126.
3. Harris, C.C. (1996) p53 tumour suppressor gene: from basic research laboratory to the clinic - an abridged history. Carcinogenesis, 17, 1187-1198.
4. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
5. Bray, S.E., Schorl, C. and Hall, P.A. (1998) The challenge of p53: linking biology, biochemistry and patient management. Stem Cells, 16, 248-260.
6. Hainaut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., Harris, C.C. and Montesano, R. (1998) IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res., 26, 205-213.
7. Hall, P.A and Lane, D.P. (1997) p53-a developing role? Curr. Biol., 7, 144-147.
8. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A.Jr. Butel, J.S. and Bradley, A. (1992) Mice delicient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
9. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
10. Venkatachalam, S., Shi, Y.P., Jones, S.N., Vogel, H., Bradley, A., Pinkel, D. and Donehower, L.A. (1998) Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMRO J., 17, 4657-4667.
11. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhihited by interleukin-6. Nature, 352, 345-347.
12. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Tren, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumour suppression. Cell, 75, 817-825.
13. Nakamura, T., Pichel, J.G., Williams-Simons, L. and Westphal, H. (1995) An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. Proc. Natl Acad. Sci. USA, 92, 6142-6146.
14. Godley, L.A., Kopp, J.B., Eckhaus, M., Paglino, J.J., Owens, J. and Varmus, H.E. (1996) Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev., 10, 836-850.
15. Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M.G., Bossi, G., Cimino, L., Crescenzi, M. and Sacchi, A. (1996) Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol., 134, 193-204.
16. Eizenberg, O., Faber-Elman, A., Gottlieb, E., Oren, M., Rotter, V. and Schwartz, M. (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol., 16, 5178-5185.
17. Moles, J.P., Schiller, J.T., Tesniere, A., Leigh, I.M., Guilhou, J.J. and Bassel-Seguin, N. (1994) Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J. Cell Sci., 107, 435-441.
18. Giacca, A.J. and Kastan, M. (1996) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 10, 1054-1072.
19. Agarwal, M.L., Taylor, W.R., Chernov, M.V. Chernova, O.B. and Stark, G.R. (1998) The p53 network. J. Biol. Chem., 273, 1-4.
20. Bourdon, J.C., Deguin-Chambon, V., Lelong, J.C., Dessen, P., May, B., Debuire, B. and May, E. (1997) Further characterisation of the p53 responsive element-identitication of new candidate genes for transactivation by p53. Oncogene, 14, 85-94.
21. Midgley, C.A., Owens, B., Briscoe, C.V., Thomas, D.B., Lane, D.P. and Hall, P.A. (1995) Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J. Cell Sci., 108, 1843-1841.
22. MacCallum, D.E., Hupp, T.R., Midgley, C.A., Stuart, D., Campbell, S.J., Harper, A., Walsh, F.S., Wright, E.G., Balmain, A., Lane, D.P. and Hall, P.A. (1996) The p53 response to ionising radiation in adult and developing murine tissues. Oncogene, 13, 2575-2587.
23. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. and Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
24. Jost, C.A., Marin, M.C. and Kaelin, W.G. Jr (1997) p73 is a human p53-related protein that can induce apoptosis. Nature, 389, 191-194.
25. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V., Andrews, N.C., Caput, D. and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2, 305-316.
26. Schmale, H. and Bamberger, C. (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene, 15, 1363-1367.
27. Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J. and Sidransky, D. (1998) A new human p53 homologue. Nature Med., 4, 747-748.
28. Osada, M., Ohha, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M. and Ikawa, S. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Med., 4, 839-843.
29. Senoo, M., Seki, N., Ohira, M., Sugano, S., Watanabe, M., Tachibana, M., Tanaka, T., Shinkai, Y. and Kato, H. (1998) A second p53-related protein, p73L, with high homology to p73. Biochem. Biophys. Res. Commun., 30, 603-607.
30. Ishioka, C., Englert, C., Winge, P., Yan, Y.X., Engelstein, M. and Friend, S.H. (1995) Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene, 20, 1485-1492.
31. Kaelin, W.G. Jr (1998) Another p53 Doppelganger? Science, 281, 57-58.
32. Harlow, E. and Lane, D.P. (1998) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N.E. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol., 106, 761-771.
34. Chilosi, M., Iannucci, A., Menestrina, F., Lestani, M., Scarpa, A., Bonetti, F., Fiore-Donati, L., DiPasquale, B., Pizzolo, G. and Palestro, G. (1987) Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases. Am. J. Pathol., 128, 464-470.
35. Wright, N.A. and Alison, M. (1984) The Biology of Epithelial Cell Populations. Oxford University Press, Oxford, UK.
36. Gong, J.G., Costanzo, A., Yang, H.Q., Melino, G., Kaelin, W.G., Levrero, M. and Wang, J.Y.J. (1999) The tyrosine kinase c-abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature, 399, 806-809.
37. Agami, R., Biandino, G., Oren, M. and Shaul, Y. (1999) Interaction of c-abl and p73a and their collaboration to induce apoptosis. Nature, 399, 809-813.
38. Yuan, J.-M., Shioya, H., Ishiko, T., Sun, X., Huang, Y.Y., Gu, J., Lu, H., Kharbanda, S., Wichselbaum, R. and Kufe, R. (1999) p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature, 399, 814-817.
39. Hall, P.A., McKee, P.H., Menage, H. du P., Dover, R. and Lane, D.P. (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207.
40. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G. (1998) Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med., 188, 1763-1768.
41. Matlashewski, G., Pim, D., Banks, L. and Crawford, L. (1987) Alternative splicing of human p53 transcripts. Oncogene Res., 1, 77-85.
42. Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O. and Rotter, V. (1986) Immunologically distinct p53 molecules generated by alternative splicing. Mol. Cell. Biol., 6, 3232-3239.
43. Almog, N., Li, R., Peled, A., Schwartz, D., Wolkowicz, R., Goldfinger, N., Pei, H. and Rotter, V. (1997) The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells. Mol. Cell. Biol., 17, 713-722.
44. Rehberger, P.A., Richter, K.H., Schwartz, D., Goldfinger, N., Oskato, R., Almog, N., Marks, F. and Rotter, V. (1997) Differential expression of the regularly spliced wild-type p53 and its COOH-terminal alternatively spliced form during epidermal differentiation. Cell Growth Differ., 8, 851-860.
45. Wu, L., Bayle, J.H., Elenbaas, B., Pavletich, N.P. and Levine, A.J. (1995) Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids. Mol. Cell. Biol., 15, 497-504.
46. Wu, Y., Liu, Y., Lee, L., Miner, Z. and Kulesz-Martin, M. (1994) Wild-type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells. EMBO J., 13, 4823-4830.
47. Zhu, J., Jiang, J., Zhou, W. and Chen, X. (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res., 58, 5061-5065.
48. Nylander, K., Bourdon, J.-C., Bray, S., Kay, R., Hart, I. and Hall, P.A. (2000) Transcriptional activation of tyrosinase by p53 links UV irradiation to the protective tanning response. J. Pathol., in press.
49. Norton, J.D., Deed, R.W., Craggs, G. and Sablitzky, F. (1998) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol., 8, 58-65.
50. Wice, B.M. and Gordon, J.I. (1998) Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J. Biol. Chem., 273, 25310-25319.
51. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R.T., Tabin, C., Sharpe, A., Caput, D., Crum, C. and McKeon, F. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
52. Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R. and Bradley, A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
53. van Bokhoven, H., Jung, M., Smits, A.P., van Beersum, S., Ruschendorf, F., van Steensel, M., Veenstra, M., Tuerlings, J.H., Mariman, E.C., Brunner, H.G., Wienker, T.F., Reis, A., Ropers, H.H. and Hamel, B.C. (1999) Limb mammary syndrome: a new genetic disorder with mammary hypoplasia, ectrodactyly, and other hand/foot anomalies maps to human chromosome 3q27. Am. J. Hum. Genet., 64, 538-546.